|
[1] 中国居民营养与慢性病状况报告(2020年)[J]. 营养学报, 2020, 42(6): 521. Report on the nutrition and chronic diseases status of Chinese residents 2020[J]. Acta Nutr Sin, 2020, 42(6): 521.(in Chinese) [2] Zhou J, Zhou F, Wang W, et al.Epidemiological features of NAFLD from 1999 to 2018 in China[J]. Hepatology, 2020, 71(5):1851-1864. [3] 李东丹, 闫洁, 王美辰, 等. 非酒精性脂肪性肝病肥胖儿童人体成分及其影响因素分析[J]. 中国实用儿科杂志, 2023, 38(7): 525-529. Li DD, Yan J, Wang MC, et al. Analysis of body composition and risk factors of non-alcoholic fatty liver disease in obese children[J]. Chin J Pract Pediatr, 2023, 38(7): 525-529. (in Chinese) [4] 中华人民共和国国家卫生健康委员会医政司. 肥胖症中国诊疗指南(2024年版)[J]. 协和医学杂志, 2025, 16(1): 90-108. Department of Medical Administration, National Health Commission of the People's Republic of China. Chinese Guidelines for the Clinical Management of Obesity (2024 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 90-108. (in Chinese) [5] 李婕, 任万华. 儿童非酒精性脂肪性肝病的诊治对策[J]. 中华肝脏病杂志, 2020, 28(3): 208-212. Li J, Ren WH. Diagnosis and therapeutic strategies for non-alcoholic fatty liver disease in children[J]. Chin J Hepatol, 2020, 28(3): 208-212. (in Chinese) [6] 李辉, 季成叶, 宗心南, 等. 中国0~18岁儿童、青少年体块指数的生长曲线[J]. 中华儿科杂志, 2009, 47(7): 493-498. Li H, Ji CY, Zong XN, et al. Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years[J]. Chin J Pediatr, 2009, 47(7): 493-498. (in Chinese) [7] 周雪莲, 傅君芬. 儿童非酒精性脂肪肝病诊断与治疗专家共识[J]. 中国实用儿科杂志, 2018, 33(7): 487-492. Zhou XL, Fu JF. Expert consensus on the diagnosis and treatment of nonalcoholic fatty liver disease in children[J]. Chin J Pract Pediatr, 2018, 33(7): 487-492. (in Chinese) [8] 范晖, 闫银坤, 米杰. 中国3~17岁儿童性别、年龄别和身高别血压参照标准[J]. 中华高血压杂志, 2017, 25(5): 428-435. Fan H, Yan YK, Mi J. Updating blood pressure references for Chinese children aged 3-17 years[J]. Chin J Hypertens, 2017, 25(5): 428-435. (in Chinese) [9] Eslam M, Alkhouri N, Vajro P, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: An international expert consensus statement[J]. Lancet Gastroenterol Hepatol, 2021, 6(10): 864-873. [10] Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature[J].Hepatology, 2023, 78(6): 1966-1986. [11] 王雨, 杨志然, 陈润花. 中国儿童非酒精性脂肪性肝病患病率的Meta分析[J]. 中国儿童保健杂志, 2022, 30(7): 764-769. Wang Y, Yang ZR, Chen RH. Meta-analysis of the prevalence of non-alcoholic fatty liver disease in Chinese children[J]. Chin J Child Health Care, 2022, 30(7): 764-769. (in Chinese) [12] 陈新春, 寇永妹, 刘晓璐, 等. 唐山市7~14岁肥胖儿童非酒精性脂肪肝流行现状及危险因素初步分析[J]. 中国儿童保健杂志, 2021, 29(6): 669-673. Chen XC, Kou YM, Liu XL, et al. Prevalence and risk factors of nonalcoholic fatty liver disease among obesity children aged 7 to 14 years in Tangshan city[J]. Chin J Child Health Care, 2021, 29(6): 669-673. (in Chinese) [13] Qin L, Zhao W, Lin Z, et al. Clinical and lipid metabolic responses to diacylglycerol oil administration in Chinese adults with overweight/obesity or central obesity: A randomized, double-blind, placebo-controlled trial[J]. Food Funct, 2026, 17(1): 243-258. [14] Wang D, Zhang J, Yang X, et al. Acetylation of the mitochondrial chaperone GRP75 governs ER-mitochondrial calcium homeostasis and hepatocyte insulin resistance[J]. Adv Sci, 2025, 12(46): e08991. [15] 王宪红, 高志峰. 非酒精性脂肪肝患者病情严重程度与炎性因子的相关性研究[J]. 实验与检验医学, 2021, 39(5): 1159-1160, 1171. [16] 刘勤, 牛春燕. 由“二次打击”到“多重打击”: 发病机制的演变带给非酒精性脂肪性肝病的治疗启示[J]. 世界华人消化杂志, 2019, 27(19): 1171-1178. Liu Q, Niu CY. From “two hit theory” to “multiple hit theory”: Implications of evolution of pathogenesis concepts for treatment of non-alcoholic fatty liver disease[J]. World Chin J Dig, 2019, 27(19): 1171-1178. (in Chinese) [17] Li J, Li Y, Zhou X, et al. Adipocytes orchestrate obesity-related chronic inflammation through β2-microglobulin[J].Sig Transduct Target Ther, 2025, 10: 394. [18] Yin J, Gao Z, He Q, et al. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue[J]. Am J Physiol Endocrinol Metab, 2009, 296(2): E333-E342. [19] Huang Y, Sulek K, Stinson SE, et al. Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesity[J]. Nat Med, 2025, 31(1): 294-305. [20] Mann J, Valenti L, Scorletti E, et al. Nonalcoholic fatty liver disease in children[J]. Semin Liver Dis, 2018, 38(1):1-13. [21] 丁剑波, 金爱华, 李秀惠, 等. 尿酸在非酒精性脂肪性肝病发生发展中的作用及机制[J]. 肝脏, 2025, 30(2): 272-275. [22] Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children[J]. J Pediatr Gastroenterol Nutr, 2017, 64(2): 319-334. [23] Lu Y, Wang Q, Yu L, et al. Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease[J]. J Clin Lab Anal, 2020, 34(7): e23285. [24] 史俊奇, 张慧, 周海燕, 等. 非酒精性脂肪肝病儿童干预前后血清细胞因子水平的纵向变化[J]. 浙江临床医学, 2024, 26(3): 394-397. [25] Yang L, Li M, Zhao M, et al. Resolution of metabolic dysfunction improves liver health among Chinese children: Evidence from two prospective cohorts[J]. Clin Gastroenterol Hepatol, 2026,24(6):1635-1643. [26] 李宁, 郑红霞, 邰苏豫, 等. 军事飞行人员非酒精性脂肪肝病患者白细胞计数、C反应蛋白、尿酸与糖脂代谢、胰岛素抵抗和肝纤维化指标的相关性研究[J]. 现代生物医学进展, 2022, 22(20): 3962-3965, 3971. Li N, Zheng HX, Tai SY, et al. Correlation study between leukocyte count, C-reactive protein, uric acid and glucose and lipid metabolism, insulin resistance and liver fibrosis indexes in military pilots with nonalcoholic fatty liver disease[J]. Prog Mod Biomed, 2022, 22(20): 3962-3965, 3971. (in Chinese) [27] Talukdar S, Oh DY, Bandyopadhyay G, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase[J]. Nat Med, 2012, 18(9): 1407-1412. [28] Crespo M, Gonzalez-Teran B, Nikolic I, et al. Neutrophil infiltration regulates clock-gene expression to organize daily hepatic metabolism[J]. eLife, 2020, 9: e59258. [29] 吴钟英, 李鹏. 非酒精性脂肪性肝病的病理生理机制研究进展[J]. 贵州医药, 2022, 46(3): 357-359. [30] 王英, 骆培良, 白华, 等. 血尿酸及性激素水平与肥胖合并非酒精性脂肪肝儿童的相关性[J]. 安徽医药, 2024, 28(11): 2205-2212. Wang Y, Luo PL, Bai H, et al. Correlation between serum uric acid, sex hormones and non-alcoholic fatty liver disease in obese children[J]. Anhui Med Pharm J, 2024, 28(11): 2205-2212. (in Chinese)
|